Cerity Partners’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$567K Buy
24,327
+10,639
+78% +$229K ﹤0.01% 2208
2025
Q4
$274K Sell
13,688
-1,712
-11% -$33.4K ﹤0.01% 2461
2025
Q3
$281K Buy
+15,400
New +$300K ﹤0.01% 2323
2021
Q1
Sell
-13,165
Closed -$163K 721
2020
Q4
$163K Buy
+13,165
New +$142K 0.01% 613
2019
Q1
Sell
-15,444
Closed -$269K 546
2018
Q4
$269K Sell
15,444
-378
-2% -$6.14K 0.02% 426
2018
Q3
$241K Buy
15,822
+2,328
+17% +$33.5K 0.02% 473
2018
Q2
$186K Buy
+13,494
New +$202K 0.01% 517

Other funds holding INVA

Cerity Partners's INVA Position: Q1 2026 in Review

Cerity Partners increased its Innoviva (INVA) stake by 78% in Q1 2026, buying an estimated $229K and bringing the position to 24,327 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

Cerity Partners first reported a position in INVA in Q2 2018 and has held it in 7 quarters since. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Cerity Partners held 24,327 shares of Innoviva worth $567K as of Q1 2026.
  • Cerity Partners bought 10,639 Innoviva shares in Q1 2026, an estimated $229K.
  • Innoviva made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2208 holding.
  • Cerity Partners first reported a position in Innoviva in Q2 2018 and has held it in 7 quarters since.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.